Palvella Therapeutics, Inc (PVLA)
Healthcare
Biotechnology
139.00 $
-7.4%
vs. previous close
Closing price · As of: 31. Jul 2026
Palvella Therapeutics, Inc (PVLA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -11 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q1 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.0 | -9.7 | -20 | -1.1 | -1.6 | -2.7 | -5.4 | -6.8 | -5.4 | -7.9 | -4.9 | -11 | -29 | |
| – | 0.7 | – | – | – | – | – | – | – | – | – | – | – | |
| 0.1 | – | – | 0.1 | 0.2 | 0.2 | 0.3 | 1.1 | 1.4 | 1.8 | 1.1 | 3.4 | 7.7 | |
| 0.0 | -16 | -14 | 0.4 | 1.0 | 1.9 | -3.6 | -1.0 | 1.1 | -0.2 | 3.8 | -0.4 | 4.4 | |
| 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | -2.0 | 3.4 | – | – | – | -3.4 | – | – | – | – | -55 | – | |
| – | – | – | – | – | 2.4 | 66 | – | – | 0.0 | 0.0 | – | – | |
| – | – | 0.0 | 0.0 | 9.9 | 2.4 | 75 | -1.2 | 0.3 | 0.2 | 0.0 | 215 | 215 | |
| -4.0 | -12 | -15 | 1.7 | 0.6 | -0.3 | 69 | 56 | -5.2 | -6.9 | -5.6 | 148 | 131 | |
| -4.0 | -9.8 | -20 | -1.1 | -1.6 | -2.7 | -5.4 | -6.8 | -5.4 | -7.9 | -4.9 | -11 | -29 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.